首页 | 本学科首页   官方微博 | 高级检索  
检索        


Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
Authors:Hellsten Rebecka  Johansson Martin  Dahlman Anna  Dizeyi Nishtman  Sterner Olov  Bjartell Anders
Institution:1. Division of Urological Cancers, Department of Clinical Sciences Malm?, Lund University, Malm?, Sweden;2. Division of Organic Chemistry, Department of Chemistry, Lund University, Malm?, Sweden;3. Division of Urological Research, Department of Clinical Sciences Malm?, Lund University, Malm?, Sweden;4. Department of Surgery, Urology Services, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan‐Kettering Cancer Center, New York, NY
Abstract:
Keywords:natural products  xenograft  LNCaP  PC‐3  DU‐145
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号